Biosimilars: a snapshot of latest developments
Clinical update Previous     Next

Biosimilars: a snapshot of latest developments

Daniel Allen Health writer

Essential facts

Biosimilar medicines are made or derived from biological rather than chemical ingredients. As with standard medicines, when a biologic’s patent expires, it can be reproduced by other companies.

Cancer Nursing Practice. 18, 3, 11-11. doi: 10.7748/cnp.18.3.11.s11

Want to read more?

Subscribe for unlimited access

Try 1 month’s access for just £1 and get:

Your subscription package includes:
  • Full access to the website and the online archive
  • Bi-monthly digital edition
  • RCNi Portfolio and interactive CPD quizzes
  • RCNi Learning with 200+ evidence-based modules
  • 10 articles a month from any other RCNi journal
Subscribe
RCN student member? Try Nursing Standard Student
Already subscribed? Log in

Alternatively, you can purchase access to this article for the next seven days. Buy now

Or